Profile data is unavailable for this security.
About the company
Sigyn Therapeutics, Inc. (Sigyn) is a development-stage company. The Company is focused on creating therapeutic solutions that address unmet needs in global health. The Company's product candidate, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders. Its treatment indications include endotoxemia and inflammation in end-stage renal disease (dialysis) patients, sepsis (a cause of hospital deaths), community-acquired pneumonia (a cause of death among infectious diseases), and emerging pandemic threats. Sigyn Therapy is a single-use disposable device that is deployable on the global infrastructure of hemodialysis and continuous renal replacement therapy (CRRT) machines. The Company’s development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the tumor site delivery of chemotherapy, and ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis.
- Revenue in USD (TTM)0.00
- Net income in USD-3.56m
- Incorporated2014
- Employees5.00
- LocationSigyn Therapeutics Inc9190 W Olympic Blvd # 263BEVERLY HILLS 90212United StatesUSA
- Phone+1 (619) 368-2000
- Fax+1 (845) 818-3588
- Websitehttps://www.sigyntherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ReShape Lifesciences Inc | 8.34m | -10.92m | 4.58m | 31.00 | -- | 1.01 | -- | 0.5496 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
Therapeutic Solutions International Inc | 97.68k | -2.18m | 4.59m | 3.00 | -- | 3.00 | -- | 47.01 | -0.0006 | -0.0006 | 0.00003 | 0.0003 | 0.0257 | 1.30 | 5.44 | 32,560.00 | -63.47 | -162.32 | -172.17 | -- | 63.36 | 67.79 | -2,468.37 | -2,391.85 | 0.4652 | -6.42 | 0.2868 | -- | -52.13 | 95.35 | 43.11 | -- | -- | -- |
Pressure Biosciences Inc | 1.98m | -35.20m | 4.68m | 15.00 | -- | -- | -- | 2.37 | -1.65 | -1.65 | 0.0885 | -0.9261 | 1.29 | 2.38 | 8.86 | 131,850.70 | -1,916.46 | -872.30 | -- | -- | 40.43 | 32.33 | -1,482.20 | -1,066.48 | 0.0136 | -0.595 | -- | -- | 14.37 | -4.25 | -97.72 | -- | -- | -- |
ADM Tronics Unlimited Inc | 2.85m | -716.86k | 4.91m | 7.00 | -- | 4.45 | -- | 1.72 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
BioSig Technologies Inc | 27.00k | -25.25m | 5.06m | 4.00 | -- | -- | -- | 187.25 | -3.24 | -3.24 | 0.0033 | -0.3776 | 0.008 | -- | 1.74 | 6,750.00 | -728.65 | -269.73 | -- | -363.11 | 48.15 | -- | -91,566.66 | -24,485.73 | -- | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
Nu-Med Plus Inc | 0.00 | -119.16k | 5.19m | 2.00 | -- | -- | -- | -- | -0.0014 | -0.0014 | 0.00 | -0.002 | 0.00 | -- | -- | 0.00 | -350.01 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -22.74 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
Venus Concept Inc | 73.30m | -37.39m | 5.29m | 304.00 | -- | -- | -- | 0.0722 | -6.69 | -6.69 | 13.12 | -3.54 | 0.7409 | 1.06 | 2.21 | 241,125.00 | -37.61 | -32.71 | -56.83 | -44.01 | 68.37 | 68.16 | -50.77 | -48.50 | 1.35 | -3.44 | 1.40 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
Bionoid Pharma Inc | 0.00 | 1.35m | 5.40m | 13.00 | 0.0882 | -- | 3.99 | -- | 1.13 | 1.13 | 0.00 | -0.1744 | -- | -- | -- | -- | -- | -506.64 | -- | -- | -- | -- | -- | -- | -- | 327.24 | -- | -- | -- | -- | -31.55 | -- | 26.01 | -- |
Guided Therapeutics Inc | 82.00k | -3.23m | 5.62m | 4.00 | -- | -- | -- | 68.59 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
VirExit Technologies Inc | 0.00 | -1.80m | 6.05m | -- | -- | -- | -- | -- | -0.0932 | -0.113 | 0.00 | -0.0367 | 0.00 | -- | -- | -- | -6,103.43 | -- | -- | -- | -- | -- | -- | -- | -- | -3.66 | -- | -- | -100.00 | -- | 19.08 | -- | -- | -- |
Sonendo Inc | 40.19m | -57.74m | 6.16m | 216.00 | -- | 0.2513 | -- | 0.1534 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Vivos Therapeutics Inc | 13.36m | -15.64m | 7.20m | 114.00 | -- | 10.47 | -- | 0.5386 | -11.00 | -11.00 | 8.73 | 0.2131 | 0.9247 | -- | 31.59 | 117,219.30 | -108.24 | -89.72 | -243.30 | -149.70 | 58.90 | 70.20 | -117.06 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
Neurometrix Inc | 5.27m | -7.98m | 7.46m | 26.00 | -- | 0.393 | -- | 1.42 | -6.32 | -6.32 | 4.20 | 9.44 | 0.2381 | 1.25 | 10.08 | 202,700.40 | -36.07 | -23.24 | -38.94 | -27.26 | 61.97 | 59.17 | -151.51 | -48.88 | 10.11 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Biomerica Inc | 5.41m | -6.35m | 7.54m | 62.00 | -- | 0.9658 | -- | 1.40 | -0.3789 | -0.3789 | 0.3224 | 0.4642 | 0.5827 | 2.28 | 5.74 | 87,180.80 | -68.45 | -43.55 | -83.73 | -50.32 | 11.41 | 15.75 | -117.46 | -55.86 | 3.37 | -- | 0.00 | -- | -71.71 | -0.8229 | -57.58 | -- | -9.76 | -- |
PAVmed Inc | 3.02m | -71.05m | 7.82m | 107.00 | -- | -- | -- | 2.59 | -9.08 | -9.08 | 0.3874 | -7.76 | 0.0588 | -- | 64.17 | 28,186.92 | -147.38 | -154.56 | -- | -1,152.82 | -126.09 | -- | -2,505.37 | -8,764.89 | 0.5301 | -8.32 | 1.82 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
Holder | Shares | % Held |
---|---|---|
Brio Capital Management LLCas of 09 Jan 2024 | 2.15k | 0.18% |